| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 14,876,163 | 13,230,205 | 11,155,090 | | Cost of Revenue | 6,653,794 | 6,018,877 | 5,241,891 | | | Gross Profit | 8,222,369 | 7,211,328 | 5,913,199 | | | Operating Expenses | | Research Development | 1,721,330 | 1,526,928 | 1,254,193 | | Selling General and Administrative | 4,601,588 | 3,912,688 | 3,253,274 | | Non Recurring | 330,515 | 32,460 | 197,974 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,568,936 | 1,739,252 | 1,207,758 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 207,644 | 393,172 | 216,383 | | Earnings Before Interest And Taxes | 1,776,580 | 2,132,424 | 1,424,141 | | Interest Expense | 73,774 | 72,855 | 34,123 | | Income Before Tax | 1,702,806 | 2,059,569 | 1,390,018 | | Income Tax Expense | 312,514 | 378,446 | 162,664 | | Minority Interest | (44,725) | (15,455) |
-
| | | | Net Income From Continuing Ops | 1,345,567 | 1,665,668 | 1,227,354 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| (3,372) | | Other Items |
-
|
-
|
-
| | | | Net Income | 1,345,567 | 1,665,668 | 1,223,982 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,345,567 | $1,665,668 | $1,223,982 |
|
0.16% Nasdaq 0.00%
Income Statement
